Glucagon‐like peptide‐1 analogues reduce alcohol intake
Diabetes, Obesity and Metabolism · 2025-03 · 27 (3) · 1601-1604
DOI: 10.1111/dom.16152 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 02.01.2025. Verfasst von Maurice O'Farrell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medication Weight Loss Clinic, Dublin, Ireland. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Medication Weight Loss Clinic, Dublin, Ireland.
- Department of Family and Community Medicine, College of Medicine, Qassim University, Buraidah, Saudi Arabia.
- Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
ORCID-Profile: Maurice O'Farrell, Faisal I Almohaileb, Carel W le Roux
Zitieren
APA
O'Farrell, M., Almohaileb, F. I., & le Roux, C. W. (2025). Glucagon‐like peptide‐1 analogues reduce alcohol intake. Diabetes, Obesity and Metabolism, 27(3), 1601-1604. https://doi.org/10.1111/dom.16152
Vancouver
O'Farrell M, Almohaileb FI, le Roux CW. Glucagon‐like peptide‐1 analogues reduce alcohol intake. Diabetes, Obesity and Metabolism. 2025;27(3):1601-1604. doi:10.1111/dom.16152
BibTeX
@article{OFarrell2025,
author = {O'Farrell, Maurice and Almohaileb, Faisal I and le Roux, Carel W},
title = {Glucagon‐like peptide‐1 analogues reduce alcohol intake},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {3},
pages = {1601--1604},
doi = {10.1111/dom.16152}
}
EUVIMED